Effect of chemotherapy on prognosis in patients with primary pancreatic signet ring cell carcinoma: A large real-world study based on machine learning
Authors:
Open Access
- 13 May 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (5) , e0302685
Abstract
Background: Primary pancreatic signet ring cell carcinoma (PSRCC), an extremely rare histologic variant of pancreatic cancer, has a poor prognosis. This study aimed to investigate the prognostic value of chemotherapy in PSRCC. Methods: Patients with PSRCC between 2000 and 2019 were identified using the Surveillance Epidemiology and End Results (SEER) database. The main outcomes in this study were cancer-specific survival (CSS) and overall survival (OS). The baseline characteristics of patients were compared using Pearson’s Chi-square test. Kaplan-Meier analysis was used to generate the survival curves. Least absolute shrinkage and selection operator (LASSO), univariate and multivariate Cox regression models, and Random Survival Forest model were used to analyze the prognostic variables for OS and CSS. The variance inflation factors (VIFs) were used to analyze whether there was an overfitting problem. Results: A total of 588 patients were identified. Chemotherapy was an independent prognostic factor for OS and CSS, and significantly associated with OS (HR = 0.33, 95% CI = 0.27–0.40, P <0.001) and CSS (HR = 0.32, 95% CI = 0.26–0.39, P <0.001). Conclusions: Chemotherapy showed beneficial effects on OS and CSS in patients with PSRCC and should be recommended in clinical practice.Keywords
This publication has 41 references indexed in Scilit:
- Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factorInternational Journal of Cancer, 2014
- Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysisThe Lancet Oncology, 2013
- A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with CisplatinAnnals of Surgical Oncology, 2007
- Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic CancerJAMA, 2007
- Clinical relevance of thymidylate synthase expression in the signet ring cell histotype component of colorectal carcinomaEuropean Journal of Cancer, 2004
- [Signet ring cell carcinoma of the pancreas: a case report].2002
- Pancreatic Endocrine Tumor with Signet Ring Cell Features: A Case Report with Novel Ultrastructural ObservationsUltrastructural Pathology, 1998
- Rare primary signet ring carcinoma of the pancreas.1995
- Signet-ring mucinous adenocarcinoma of the pancreas.1994
- Signet ring carcinoma of the pancreas, a rare variant with very high CEA valuesDigestive Diseases and Sciences, 1984